Predictive factors, preventive implications, and personalized surgical strategies for bone metastasis from lung cancer: population-based approach with a comprehensive cancer center-based study

[1]  M. Adamkov,et al.  Protective Effects of Flavonoids Against Mitochondriopathies and Associated Pathologies: Focus on the Predictive Approach and Personalized Prevention , 2021, International journal of molecular sciences.

[2]  W. Chien,et al.  Incidence of bone metastases in patients with organ‐specific cancers: A nationwide population‐based cohort study , 2021, International journal of clinical practice.

[3]  Nicholas G Zaorsky,et al.  Epidemiology of bone metastases. , 2020, Bone.

[4]  M. Filetti,et al.  High Prevalence and Early Occurrence of Skeletal Complications in EGFR Mutated NSCLC Patients With Bone Metastases , 2020, Frontiers in Oncology.

[5]  J. Buchowski,et al.  Spine-specific skeletal related events and mortality in non-small cell lung cancer patients: a single-institution analysis. , 2020, Journal of neurosurgery. Spine.

[6]  D. Garbossa,et al.  Separation surgery for metastatic epidural spinal cord compression: A qualitative review , 2020, Journal of bone oncology.

[7]  D. Haschtmann,et al.  Can the Charlson Comorbidity Index be used to predict the ASA grade in patients undergoing spine surgery? , 2020, European Spine Journal.

[8]  P. Kubatka,et al.  Liquid Biopsy is Instrumental for 3PM Dimensional Solutions in Cancer Management , 2020, Journal of clinical medicine.

[9]  Yaqiang Cao,et al.  BMP2 signalling activation enhances bone metastases of non‐small cell lung cancer , 2020, Journal of cellular and molecular medicine.

[10]  H. Q. Huy,et al.  Cement Leakage in Percutaneous Vertebroplasty for Multiple Osteoporotic Vertebral Compression Fractures: A Prospective Cohort Study , 2020, Orthopedic research and reviews.

[11]  R. Kučera,et al.  Prostate cancer management: long-term beliefs, epidemic developments in the early twenty-first century and 3PM dimensional solutions , 2020, EPMA Journal.

[12]  Zhongqiang Chen,et al.  The effect of bone cement distribution on the outcome of percutaneous Vertebroplasty: a case cohort study , 2020, BMC Musculoskeletal Disorders.

[13]  Xiumei Wang,et al.  Bioactive poly (methyl methacrylate) bone cement for the treatment of osteoporotic vertebral compression fractures , 2020, Theranostics.

[14]  V. Holubekova,et al.  Rho GTPases in Gynecologic Cancers: In-Depth Analysis toward the Paradigm Change from Reactive to Predictive, Preventive, and Personalized Medical Approach Benefiting the Patient and Healthcare , 2020, Cancers.

[15]  S. Choi,et al.  The Incidence and Management Trends of Metastatic Spinal Tumors in South Korea: A Nationwide Population-based Study. , 2020, Spine.

[16]  Zhou Xing,et al.  Efficacy Analysis of Separation Surgery Combined with SBRT for Spinal Metastases—A Long‐Term Follow‐Up Study Based on Patients with Spinal Metastatic Tumor in a Single‐Center , 2020, Orthopaedic surgery.

[17]  M. Bilsky,et al.  Hybrid Therapy for Spinal Metastases. , 2020, Neurosurgery clinics of North America.

[18]  K. Bussard,et al.  Novel Techniques to Study the Bone-Tumor Microenvironment. , 2020, Advances in experimental medicine and biology.

[19]  F. Bidault,et al.  Anemia and neutrophil‐to‐lymphocyte ratio in laryngeal cancer treated with induction chemotherapy , 2020, The Laryngoscope.

[20]  M. Preul,et al.  Percutaneous Vertebroplasty: A History of Procedure, Technology, Culture, Specialty, and Economics. , 2019, Neuroimaging clinics of North America.

[21]  Biru Liang,et al.  Efficacy and safety of using high viscosity bone cement vertebroplasty in the treatment of osteoporotic vertebral compression fractures with intravertebral cleft. , 2019, World neurosurgery.

[22]  S. Ruchholtz,et al.  Development of the Barthel Index 5 years after hip fracture: Results of a prospective study , 2019, Geriatrics & gerontology international.

[23]  Xiaolei Zhang,et al.  The homogeneous and heterogeneous risk factors for occurrence and prognosis in lung cancer patients with bone metastasis , 2019, Journal of bone oncology.

[24]  S. Takai,et al.  Symptoms Related to Moderate Skeletal-Related Events as Clues for the Diagnosis of Bone Metastasis. , 2019, Journal of Nippon Medical School = Nippon Ika Daigaku zasshi.

[25]  H. Verkooijen,et al.  Systematic Review of the Role of Stereotactic Radiotherapy for Bone Metastases , 2019, Journal of the National Cancer Institute.

[26]  A. Gemma,et al.  Erlotinib plus bevacizumab versus erlotinib alone in patients with EGFR-positive advanced non-squamous non-small-cell lung cancer (NEJ026): interim analysis of an open-label, randomised, multicentre, phase 3 trial. , 2019, The Lancet. Oncology.

[27]  P. Tugwell,et al.  Measurement Properties of Visual Analogue Scale, Numeric Rating Scale, and Pain Severity Subscale of the Brief Pain Inventory in Patients With Low Back Pain: A Systematic Review. , 2019, The journal of pain : official journal of the American Pain Society.

[28]  S. Kannan,et al.  Phase III Non-inferiority Study Evaluating Efficacy and Safety of Low Dose Gemcitabine Compared to Standard Dose Gemcitabine With Platinum in Advanced Squamous Lung Cancer , 2019, EClinicalMedicine.

[29]  Daniele M. Gilkes,et al.  The Contribution of the Immune System in Bone Metastasis Pathogenesis , 2019, International journal of molecular sciences.

[30]  Y. Yamada,et al.  Hybrid Therapy for Metastatic Epidural Spinal Cord Compression: Technique for Separation Surgery and Spine Radiosurgery. , 2018, Operative neurosurgery.

[31]  J. Shang,et al.  Impact of the homogeneous and heterogeneous risk factors on the incidence and survival outcome of bone metastasis in NSCLC patients , 2019, Journal of Cancer Research and Clinical Oncology.

[32]  S. Stewart,et al.  Understanding the Bone in Cancer Metastasis , 2018, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[33]  P. Algra,et al.  Clinical management of spinal metastases-The Dutch national guideline. , 2018, European journal of cancer.

[34]  Kyung-Han Lee,et al.  PET/CT features discriminate risk of metastasis among single-bone FDG lesions detected in newly diagnosed non-small-cell lung cancer patients , 2018, European Radiology.

[35]  M. Bilsky,et al.  State of the Art Treatment of Spinal Metastatic Disease , 2018, Neurosurgery.

[36]  R. Delfini,et al.  Total en-bloc spondylectomy through a posterior approach: technique and surgical outcome in thoracic metastases , 2018, Acta Neurochirurgica.

[37]  E. Biskup,et al.  Incidence, risk factors and prognostic characteristics of bone metastases and skeletal-related events (SREs) in breast cancer patients: A systematic review of the real world data , 2018, Journal of bone oncology.

[38]  Toby Richards,et al.  Perioperative Patient Blood Management to Improve Outcomes , 2017, Anesthesia and analgesia.

[39]  M. Bilsky,et al.  An integrated multidisciplinary algorithm for the management of spinal metastases: an International Spine Oncology Consortium report. , 2017, The Lancet. Oncology.

[40]  Rostyslav V Bubnov,et al.  “Pre-metastatic niches” in breast cancer: are they created by or prior to the tumour onset? “Flammer Syndrome” relevance to address the question , 2017, EPMA Journal.

[41]  X. Zhan,et al.  Pattern recognition for predictive, preventive, and personalized medicine in cancer , 2017, EPMA Journal.

[42]  Leo Joskowicz,et al.  Computer-aided surgery meets predictive, preventive, and personalized medicine , 2017, EPMA Journal.

[43]  P. Brown,et al.  Consensus guidelines for postoperative stereotactic body radiation therapy for spinal metastases: results of an international survey. , 2017, Journal of neurosurgery. Spine.

[44]  Jian Shen,et al.  Bone cement distribution in the vertebral body affects chances of recompression after percutaneous vertebroplasty treatment in elderly patients with osteoporotic vertebral compression fractures , 2017, Clinical interventions in aging.

[45]  J. Buchowski,et al.  Rapid improvements in pain and quality of life are sustained after surgery for spinal metastases in a large prospective cohort , 2016, British journal of neurosurgery.

[46]  Jianting Chen,et al.  Risk factors for bone cement leakage in percutaneous vertebroplasty: a retrospective study of four hundred and eighty five patients , 2016, International Orthopaedics.

[47]  B. Boszczyk,et al.  The surgical management of metastatic spinal tumors based on an Epidural Spinal Cord Compression (ESCC) scale. , 2015, The spine journal : official journal of the North American Spine Society.

[48]  E. Tabouret,et al.  Which one is a valuable surrogate for predicting survival between Tomita and Tokuhashi scores in patients with spinal metastases? A meta-analysis for diagnostic test accuracy and individual participant data analysis , 2015, Journal of Neuro-Oncology.

[49]  Rostyslav V Bubnov,et al.  EPMA position paper in cancer: current overview and future perspectives , 2015, EPMA Journal.

[50]  S. Hagan,et al.  Targeted therapies in colorectal cancer—an integrative view by PPPM , 2013, EPMA Journal.

[51]  A. Büttner,et al.  Heat distribution of polymerisation temperature of bone cement on the spinal canal during vertebroplasty , 2012, International Orthopaedics.

[52]  K. Tomita,et al.  Surgical Strategy for Spinal Metastases , 2001, Spine.